These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 15975686)
21. Developments in immunization against hepatitis B. Zuckerman AJ Ann Ist Super Sanita; 1987; 24(2):285-91. PubMed ID: 2969206 [No Abstract] [Full Text] [Related]
22. [Passive immunoprophylaxis in hepatitis B]. Neumayr A Wien Med Wochenschr; 1984 Aug; 134(15-16):345-50. PubMed ID: 6495746 [No Abstract] [Full Text] [Related]
23. [Post-transplant prophylaxis of the recurrence of lamivudine-resistant YMDD mutant hepatitis B virus in liver recipients]. Yang Y; Yang Y; Zhang J; Yi HM; Lu MQ; Cai CJ; Li X; Jiang N; Xu C; Li H; Wang GS; Yi SH; Zhang JF; Jiang H; Yang Q; Chen GH Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1810-2. PubMed ID: 18971179 [TBL] [Abstract][Full Text] [Related]
24. Extended HBV vaccination in liver transplant recipients for HBV-related cirrhosis: report of two successful cases. Di Paolo D; Lenci I; Trinito MO; Tisone G; Angelico M Dig Liver Dis; 2005 Oct; 37(10):793-8. PubMed ID: 16024302 [TBL] [Abstract][Full Text] [Related]
28. Influence of circadian rhythm on the efficacy of the hepatitis B vaccination. Karabay O; Temel A; Koker AG; Tokel M; Ceyhan M; Kocoglu E Vaccine; 2008 Feb; 26(9):1143-4. PubMed ID: 18255201 [No Abstract] [Full Text] [Related]
29. Effect of prior hepatitis B virus exposure on long-term risk of liver-related events after liver transplantation. Chen PH; Limketkai BN; Trilianos P; Pirtini-Cetingul M; Woreta TA; Kim B; Gulsen MT; Segev DL; Cameron AM; Gurakar A Clin Transplant; 2016 May; 30(5):579-88. PubMed ID: 26913379 [TBL] [Abstract][Full Text] [Related]
30. Review: hepatitis B immune globulin for prevention of hepatitis B infection. Zuckerman JN J Med Virol; 2007 Jul; 79(7):919-21. PubMed ID: 17516515 [TBL] [Abstract][Full Text] [Related]
31. The European Sero-Epidemiology Network 2: standardization of assay results for hepatitis B virus. Kafatos G; Anastassopoulou C; Nardone A; Andrews N; Barbara C; Boot HJ; Butur D; Davidkin I; Gelb D; Griskevicius A; Hesketh L; Icardi G; Jones L; Kra-Oz Z; Miller E; Mossong J; Nemecek V; de Ory F; Sobotová Z; Thierfelder W; Van Damme P; Hatzakis A J Viral Hepat; 2007 Apr; 14(4):260-8. PubMed ID: 17381718 [TBL] [Abstract][Full Text] [Related]
32. The global impact of vaccination against hepatitis B: a historical overview. Zanetti AR; Van Damme P; Shouval D Vaccine; 2008 Nov; 26(49):6266-73. PubMed ID: 18848855 [TBL] [Abstract][Full Text] [Related]
33. Control measures against hepatitis B infection. Frösner GG; Franco E Ann Ist Super Sanita; 1987; 24(2):267-75. PubMed ID: 2969204 [No Abstract] [Full Text] [Related]
34. Hepatitis B virus (HBV) re-infection following liver transplantation: theory and practice. Fung JJ; Eghtesad B; Todo S; Rakela J; Magnone M; Starzl TE Clin Transplant; 1995 Jun; 9(3 Pt 2):262-8. PubMed ID: 7670174 [No Abstract] [Full Text] [Related]
35. Statement on immunizing agents for the prevention of hepatitis. CMAJ; 1985 Sep; 133(6):581-5. PubMed ID: 3161607 [No Abstract] [Full Text] [Related]